Unknown

Dataset Information

0

A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites.


ABSTRACT: Isoprenoid biosynthesis through the methylerythritol phosphate (MEP) pathway generates commercially important products and is a target for antimicrobial drug development. MEP pathway regulation is poorly understood in microorganisms. Here we employ a forward genetics approach to understand MEP pathway regulation in the malaria parasite, Plasmodium falciparum. The antimalarial fosmidomycin inhibits the MEP pathway enzyme deoxyxylulose 5-phosphate reductoisomerase (DXR). Fosmidomycin-resistant P. falciparum are enriched for changes in the PF3D7_1033400 locus (hereafter referred to as PfHAD1), encoding a homologue of haloacid dehalogenase (HAD)-like sugar phosphatases. We describe the structural basis for loss-of-function PfHAD1 alleles and find that PfHAD1 dephosphorylates a variety of sugar phosphates, including glycolytic intermediates. Loss of PfHAD1 is required for fosmidomycin resistance. Parasites lacking PfHAD1 have increased MEP pathway metabolites, particularly the DXR substrate, deoxyxylulose 5-phosphate. PfHAD1 therefore controls substrate availability to the MEP pathway. Because PfHAD1 has homologues in plants and bacteria, other HAD proteins may be MEP pathway regulators.

SUBMITTER: Guggisberg AM 

PROVIDER: S-EPMC4112465 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites.

Guggisberg Ann M AM   Park Jooyoung J   Edwards Rachel L RL   Kelly Megan L ML   Hodge Dana M DM   Tolia Niraj H NH   Odom Audrey R AR  

Nature communications 20140724


Isoprenoid biosynthesis through the methylerythritol phosphate (MEP) pathway generates commercially important products and is a target for antimicrobial drug development. MEP pathway regulation is poorly understood in microorganisms. Here we employ a forward genetics approach to understand MEP pathway regulation in the malaria parasite, Plasmodium falciparum. The antimalarial fosmidomycin inhibits the MEP pathway enzyme deoxyxylulose 5-phosphate reductoisomerase (DXR). Fosmidomycin-resistant P.  ...[more]

Similar Datasets

| S-EPMC7581940 | biostudies-literature
| S-EPMC3675625 | biostudies-literature
| S-EPMC2922546 | biostudies-literature
| S-EPMC8839155 | biostudies-literature
| S-EPMC6833178 | biostudies-literature
| S-EPMC3257810 | biostudies-literature
| S-EPMC6905213 | biostudies-literature
| S-EPMC3205992 | biostudies-literature
| S-EPMC7081406 | biostudies-literature
| S-EPMC409939 | biostudies-literature